X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (430) 430
Newspaper Article (92) 92
Publication (81) 81
Book / eBook (12) 12
Dissertation (9) 9
Book Chapter (5) 5
Book Review (3) 3
Conference Proceeding (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (170) 170
index medicus (164) 164
male (110) 110
female (109) 109
oncology (93) 93
middle aged (84) 84
aged (73) 73
adult (65) 65
melanoma (62) 62
article (60) 60
cancer (47) 47
melanoma - drug therapy (41) 41
research (37) 37
aged, 80 and over (33) 33
metastatic melanoma (31) 31
risk factors (30) 30
immunotherapy (29) 29
melanoma - pathology (28) 28
analysis (26) 26
care and treatment (26) 26
animals (25) 25
metastasis (25) 25
treatment outcome (25) 25
ipilimumab (24) 24
medical research (23) 23
mutation (23) 23
survival (23) 23
antineoplastic agents - therapeutic use (22) 22
colorectal neoplasms - genetics (22) 22
mutations (22) 22
genetics & heredity (21) 21
uveal melanoma (20) 20
abridged index medicus (19) 19
risk (19) 19
skin neoplasms - drug therapy (19) 19
tumors (19) 19
genetic predisposition to disease (18) 18
studies (18) 18
colorectal cancer (17) 17
health aspects (17) 17
melanoma - genetics (17) 17
cells (16) 16
chemotherapy (16) 16
expression (16) 16
genetic aspects (16) 16
immunology (16) 16
medicine (16) 16
prognosis (16) 16
biochemistry & molecular biology (15) 15
cohort studies (15) 15
mucosal melanoma (15) 15
neoplasms - drug therapy (15) 15
therapy (15) 15
disease (14) 14
dose-response relationship, drug (14) 14
drug therapy (14) 14
malignant-melanoma (14) 14
retrospective studies (14) 14
uveal neoplasms - drug therapy (14) 14
antineoplastic agents - adverse effects (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
diagnosis (13) 13
genetics (13) 13
medicine, research & experimental (13) 13
melanoma - therapy (13) 13
multidisciplinary sciences (13) 13
polymorphism, single nucleotide (13) 13
proteins (13) 13
research article (13) 13
skin neoplasms - pathology (13) 13
young adult (13) 13
antibodies, monoclonal - therapeutic use (12) 12
clinical trials (12) 12
disease-free survival (12) 12
patients (12) 12
uveal neoplasms - pathology (12) 12
cancer therapies (11) 11
case-control studies (11) 11
development and progression (11) 11
follow-up studies (11) 11
genome-wide association study (11) 11
medicine, experimental (11) 11
melanoma - secondary (11) 11
metaanalysis (11) 11
neoplasm staging (11) 11
prevalence (11) 11
publishing industry (11) 11
trial (11) 11
adolescent (10) 10
books (10) 10
child (10) 10
diabetes (10) 10
genome-wide association (10) 10
genotype (10) 10
health risk assessment (10) 10
imatinib mesylate (10) 10
kaplan-meier estimate (10) 10
maximum tolerated dose (10) 10
medicine & public health (10) 10
melanoma - mortality (10) 10
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (6) 6
UTL at Downsview - May be requested (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UofT at Scarborough - Stacks (2) 2
Astronomy & Astrophysics - Ask at library (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Innis College - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trinity College (John W Graham) - Reference (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2011, Dx/Rx oncology series, ISBN 9780763773229, xiii, 137
Book
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, ISSN 1175-0561, 06/2019, Volume 20, Issue 3, pp. 315 - 323
Metastatic melanoma is a heterogenous disease that has served as a model for the development of both targeted therapy and immunotherapy. KIT-mutated melanoma... 
GENE-MUTATIONS | METASTATIC MELANOMA | MULTICENTER TRIAL | TYROSINE KINASE INHIBITOR | C-KIT | PHASE-II | OPEN-LABEL | BRAF | SUNITINIB THERAPY | IMATINIB MESYLATE | DERMATOLOGY
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2018, Volume 24, Issue 15, pp. 3477 - 3479
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 702 - 704
Journal Article
Journal of the American Medical Informatics Association : JAMIA, ISSN 1067-5027, 08/2019, Volume 26, Issue 11, pp. 1333 - 1343
Information overload remains a challenge for patients seeking clinical trials. We present a novel system (DQueST) that reduces information overload for trial... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 6593 - 6593
Journal Article
Expert Opinion on Orphan Drugs, ISSN 2167-8707, 09/2019
Journal Article
Oncology (Williston Park, N.Y.), ISSN 0890-9091, 09/2018, Volume 32, Issue 9, pp. e90 - e96
The therapeutic landscape for cutaneous melanoma has dramatically advanced in the last several years with the development, validation, and approval by the US... 
FOLLOW-UP SCHEDULE | HIGH-RISK MELANOMA | METASTATIC MELANOMA | DABRAFENIB PLUS TRAMETINIB | STAGE-III MELANOMA | UVEAL MELANOMA | ONCOLOGY | LONG-TERM SURVIVAL | CUTANEOUS MELANOMA | AMERICAN JOINT COMMITTEE | PATHOLOGICAL COMPLETE RESPONSE
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 4120 - 4120
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 26, pp. 2443 - 2454
Releasing T cells from inhibitory control has been a strategy exploited by the anti–CTLA-4 antibody ipilimumab. Now an antibody against a second checkpoint... 
CELL LUNG-CANCER | MEDICINE, GENERAL & INTERNAL | THERAPY | SOLID TUMORS | RESPONSE CRITERIA | IMMUNOTHERAPY | GUIDELINES | B7 FAMILY | B7-H1 | ANTITUMOR IMMUNITY | BLOCKADE | Neoplasms - metabolism | Antibodies, Monoclonal - pharmacology | Humans | Antibodies, Monoclonal - adverse effects | Programmed Cell Death 1 Receptor - metabolism | Antibodies, Monoclonal - therapeutic use | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Neoplasms - drug therapy | Dose-Response Relationship, Drug | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Melanoma - drug therapy | Adult | Female | Ligands | Antineoplastic Agents - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Programmed Cell Death 1 Receptor - immunology | Carcinoma, Renal Cell - drug therapy | Prostatic Neoplasms - drug therapy | Drugs | Dose-response relationship (Biochemistry) | Immune response | Anti-antibodies | Dosage and administration | Product/Service Evaluations | Regulation | Research | Drug therapy | Cancer | Fees & charges | Kidneys | Stock options | PD-1 protein | Laboratories | Toxicity | Tumor cells | Body weight | Lung cancer | Colorectal carcinoma | Colorectal cancer | Melanoma | Licenses | Lymphocytes T | Patients | Castration | PD-L1 protein | Antitumor activity | Prostate cancer | Drug dosages | Prostate | Clear cell-type renal cell carcinoma | Tumors | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Cancers, ISSN 2072-6694, 07/2019, Volume 11, Issue 7, p. 971
Metastatic disease from uveal melanoma occurs in almost 50% of patients suffering from this ocular tumour, with median survival from development of symptoms... 
T cell receptor | RECOGNITION | GP100 | T cell | TYROSINASE | preclinical data | CANCER-IMMUNOTHERAPY | anti-CD3 bispecific | DIRECTED EVOLUTION | clinical data | ImmTAC platform | LIVER METASTASES | THERAPY | ONCOLOGY | immunotherapy | tebentafusp | EXPRESSION | PD-1 | ASSOCIATION | metastatic uveal melanoma
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 10/2016, Volume 14, Issue 10, pp. 768 - 770
Journal Article
Oncology (Williston Park, N.Y.), ISSN 0890-9091, 04/2018, Volume 32, Issue 4, pp. 195 - 200
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. CT030 - CT030
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 10, pp. 1020 - 1030
Journal Article
American journal of clinical dermatology, 06/2019, Volume 20, Issue 3, p. 315
Metastatic melanoma is a heterogenous disease that has served as a model for the development of both targeted therapy and immunotherapy. KIT-mutated melanoma... 
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. 9056 - 9056
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.